Matt Meyerson

Charles A. Dana Chair in Human Cancer Genetics, Dana-Farber Cancer Institute

Professor of Genetics and Medicine, Harvard Medical School

Director, Center for Cancer Genomics, Dana-Farber Cancer Institute

Dana Farber Cancer Institute

617-632-4377

Meyerson Lab

Publications

Publisher Correction: Mutant p53 protein accumulation is selectively targetable by proximity-inducing drugs.

Authors: Authors: Sadagopan A, Carson M, Zamurs EJ, Garaffo N, Chang HJ, Schreiber SL, Meyerson M, Gibson WJ.
Nat Chem Biol 2025-11-12
View full abstract on Pubmed

Mutant p53 protein accumulation is selectively targetable by proximity-inducing drugs.

Authors: Authors: Sadagopan A, Carson M, Zamurs EJ, Garaffo N, Chang HJ, Schreiber SL, Meyerson M, Gibson WJ.
Nat Chem Biol 2025-11-03
View full abstract on Pubmed

Germline Variants as Risk Factors for Early-Onset Lung Adenocarcinoma.

Authors: Authors: Yermalovich A, Meyerson M.
J Thorac Oncol 2025-11-01
View full abstract on Pubmed

Lineage rewiring in lung adenocarcinoma via HNF4a and NKX2-1 dynamics.

Authors: Authors: Feng A, Yermalovich A, Meyerson M.
Genes Dev 2025-09-02
View full abstract on Pubmed

Characterization of tumor-associated microbiome in multifocal small intestinal neuroendocrine tumors (SI-NETs).

Authors: Authors: Lee IT, Dohlman A, Gao T, Zhang Z, Kasai Y, Kim GE, Thirlwell C, Nakakura E, Meyerson M, Mäkinen N.
ESMO Gastrointest Oncol 2025-09-01
View full abstract on Pubmed

High-Throughput Screening Tool to Identify Small Molecule Inhibitors of Telomerase.

Authors: Authors: Aquilanti E, Barkho S, Bozinov V, Kageler L, Garrity-Janger M, Mesleh MF, Horner S, Ranaghan MJ, Meyerson M.
ACS Chem Biol 2025-07-18
View full abstract on Pubmed

PACT prevents aberrant activation of PKR by endogenous dsRNA without sequestration.

Authors: Authors: Ahmad S, Zou T, Hwang J, Zhao L, Wang X, Davydenko A, Buchumenski I, Zhuang P, Fishbein AR, Capcha-Rodriguez D, Orgel A, Levanon EY, Myong S, Chou J, Meyerson M, Hur S.
Nat Commun 2025-04-08
View full abstract on Pubmed

Amplified dosage of the NKX2-1 lineage transcription factor controls its oncogenic role in lung adenocarcinoma.

Authors: Authors: Pulice JL, Meyerson M.
Mol Cell 2025-04-03
View full abstract on Pubmed

U2AF1 mutations rescue deleterious exon skipping induced by KRAS mutations.

Authors: Authors: Walter DM, Cho K, Sivakumar S, Lee IT, Dohlman AB, Shurberg E, Jiang KX, Gupta AA, Frampton GM, Meyerson M.
bioRxiv 2025-03-25
View full abstract on Pubmed

Editor's Note: PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR.

Authors: Authors: Sos ML, Koker M, Weir BA, Heynck S, Rabinovsky R, Zander T, Seeger JM, Weiss J, Fischer F, Frommolt P, Michel K, Peifer M, Mermel C, Girard L, Peyton M, Gazdar AF, Minna JD, Garraway LA, Kashkar H, Pao W, Meyerson M, Thomas RK.
Cancer Res 2025-03-03
View full abstract on Pubmed